Nomogram Based on Preoperative Absolute Lymphocyte Count to Predict Local Recurrence in Patients with Non-Small Cell Lung Cancer After Microwave Ablation

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer. Chest. 2013;143(5):e278S–e313S. doi:10.1378/chest.12-2359
   PubMed Web of Science ®Google Scholar
• Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. Lung Cancer. 2015;90(3):388–396. doi:10.1016/j.lungcan.2015.10.016
   PubMedGoogle Scholar
• Crocetti L, Bozzi E, Faviana P, et al. Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol. 2010;33(4):818–827. doi:10.1007/s00270-010-9869-z
   PubMedGoogle Scholar
• Vogl TJ, Naguib NN, Lehnert T, et al. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations – review article. Eur J Radiol. 2011;77(2):346–357. doi:10.1016/j.ejrad.2009.07.034
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–705e4. doi:10.1016/j.jvir.2014.08.027
   PubMed Web of Science ®Google Scholar
• Lang C, Egger F, Alireza Hoda M, et al. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: an international multicenter analysis. Lung Cancer. 2022;169:40–46. doi:10.1016/j.lungcan.2022.05.010
   PubMedGoogle Scholar
• Li Q, Kong F, Ma J, et al. Nomograms based on fibrinogen, albumin, neutrophil-lymphocyte ratio, and carbohydrate antigen 125 for predicting endometrial cancer prognosis. Cancers (Basel). 2022;14(22):5632. doi:10.3390/cancers14225632
   PubMed Web of Science ®Google Scholar
• Kim J, Kwon J, Kim M, et al. Low-dielectric-constant polyimide aerogel composite films with low water uptake. Polymer J. 2016;48(7):829–834. doi:10.1038/pj.2016.37
   Web of Science ®Google Scholar
• Clark EJ, Connor S, Taylor MA, et al. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2007;9(6):456–460. doi:10.1080/13651820701774891
   PubMedGoogle Scholar
• Mehrazin R, Uzzo RG, Kutikov A, et al. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2015;33(9):388e19–25. doi:10.1016/j.urolonc.2014.06.004
   Google Scholar
• Oh SY, Heo J, Noh OK, et al. Absolute lymphocyte count in preoperative chemoradiotherapy for rectal cancer: changes over time and prognostic significance. Technol Cancer Res Treat. 2018;17:1533033818780065. doi:10.1177/1533033818780065
   Web of Science ®Google Scholar
• Punjabi A, Barrett E, Cheng A, et al. Neutrophil-lymphocyte ratio and absolute lymphocyte count as prognostic markers in patients treated with curative-intent radiotherapy for non-small cell lung cancer. Clin Oncol. 2021;33(8):e331–e338. doi:10.1016/j.clon.2021.03.019
   Google Scholar
• Song X, Chen D, Yuan M, et al. Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy. Cancer Manag Res. 2018;10:6677–6683. doi:10.2147/CMAR.S188578
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang SH, Li H, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol. 2013;30(1):352. doi:10.1007/s12032-012-0352-3
   PubMed Web of Science ®Google Scholar
• Senders ZJ, Martin RCG. Intratumoral immunotherapy and tumor ablation: a local approach with broad potential. Cancers (Basel). 2022;14(7):1754. doi:10.3390/cancers14071754
   PubMedGoogle Scholar
• Lim W, Ridge CA, Nicholson AG, et al. The 8(th) lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8(7):709–718. doi:10.21037/qims.2018.08.02
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.026
   PubMed Web of Science ®Google Scholar
• Singh R, Mishra MK, Aggarwal H. Inflammation, immunity, and cancer. Mediators Inflamm. 2017;2017:1. doi:10.1155/2017/6027305
   Web of Science ®Google Scholar
• Rabold K, Gielen PR, Kers-Rebel ED, et al. T-cell lymphopenia in patients with advanced thyroid carcinoma is associated with poor prognosis. Oncologist. 2019;24(3):e106–e110. doi:10.1634/theoncologist.2018-0422
   PubMedGoogle Scholar
• Shibutani M, Maeda K, Nagahara H, et al. Lymphopenia associated with adjuvant chemotherapy after potentially curative surgery for colorectal cancer correlates with recurrence. Int Surg. 2016;105(1–3):146–151. doi:10.9738/intsurg-d-14-00236.1
   Google Scholar
• Nance M, Khazi Z, Kaifi J, et al. Computerized tomography-guided microwave ablation of patients with stage I non-small cell lung cancers: a single-institution retrospective study. J Clin Imaging Sci. 2021;11:7. doi:10.25259/JCIS_224_2020
   PubMedGoogle Scholar
• Jiang S, Dong C. A complex issue on CD4(+) T-cell subsets. Immunol Rev. 2013;252(1):5–11. doi:10.1111/imr.12041
   PubMedGoogle Scholar
• Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411(6835):380–384. doi:10.1038/35077246
   PubMed Web of Science ®Google Scholar
• Leuchte K, Staib E, Thelen M, et al. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma. Cancer Immunol Immunother. 2021;70(4):893–907. doi:10.1007/s00262-020-02734-1
   PubMed Web of Science ®Google Scholar
• Zhou W, Yu M, Mao X, et al. Landscape of the peripheral immune response induced by local microwave ablation in patients with breast cancer. Adv Sci (Weinh). 2022;9(17):e2200033. doi:10.1002/advs.202200033
   PubMedGoogle Scholar
• Katzman D, Wu S, Sterman DH. Immunological aspects of cryoablation of non-small cell lung cancer: a comprehensive review. J Thorac Oncol. 2018;13(5):624–635. doi:10.1016/j.jtho.2018.01.017
   PubMedGoogle Scholar
• Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar